Journal of Cellular Biochemistry · 2006 · 150 citations · 59 references
MedicineEndocrinologyBone MetabolismCellular MetabolismMineral MetabolismBone FormationOsteoblast BiologyOsteoblast FunctionOsteogenesisVitamin DVitamin D MetabolismBone Mineral HomeostasisMineralized Extracellular MatrixMineralized Matrix FormationVitamin D Effects On BoneVitamin D Endocrine SystemVitamin D MetabolitesVitamin D PhysiologyVitamin D-mediated Mineral Regulation
Vitamin D plays a major role in the regulation of mineral homeostasis and affects bone metabolism. So far, detailed knowledge on the vitamin D endocrine system in human bone cells is limited. Here we investigated the direct effects of 1alpha,25-(OH)2D3 on osteoblast differentiation and mineralization. Also, we studied the impact of 24-hydroxylation, generally considered as the first step in the degradation pathway of vitamin D, as well as the role of the nuclear and presumed membrane vitamin D receptor (VDR). For this we used a human osteoblast cell line (SV-HFO) that has the potency to differentiate during culture forming a mineralized extracellular matrix in a 3-week period. Transcriptional analyses demonstrated that both 1alpha,25-(OH)2D3 and the 24-hydroxylated metabolites 24R,25-(OH)2D3 and 1alpha,24R,25-(OH)3D3 induced gene transcription. All metabolites dose-dependently increased alkaline phosphatase (ALP) activity and osteocalcin (OC) production (protein and RNA), and directly enhanced mineralization. 1Alpha,24R,25-(OH)3D3 stimulated ALP activity and OC production most potently, while for mineralization it was equipotent to 1alpha,25-(OH)2D3. The nuclear VDR antagonist ZK159222 almost completely blocked the effects of all metabolites. Interestingly, 1beta,25-(OH)2D3, an inhibitor of membrane effects of 1alpha,25-(OH)2D3 in the intestine, induced gene transcription and increased ALP activity, OC expression and mineralization. In conclusion, not only 1alpha,25-(OH)2D3, but also the presumed 24-hydroxylated "degradation" products stimulate differentiation of human osteoblasts. 1Alpha,25-(OH)2D3 as well as the 24-hydroxylated metabolites directly enhance mineralization, with the nuclear VDR playing a central role. The intestinal antagonist 1beta,25-(OH)2D3 acts in bone as an agonist and directly stimulates mineralization in a nuclear VDR-dependent way.
59
THE QUANTITATIVE HISTOCHEMISTRY OF BRAIN
Oliver H. Lowry, Nira R. Roberts, Meiling Wu et al. · Journal of Biological Chemistry · 1954 · 812 citations · Full text
Medicine, Neurobiology, Neuroscience +10
Thomas A. Owen, Michael S. Aronow, Leesa M. Barone et al. · Endocrinology · 1991 · 350 citations
The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Mark R. Haussler, Carol A. Haussler, Peter W. Jurutka et al. · PubMed · 1997 · 339 citations
Medicine, Endocrinology, Genetics +17
René St‐Arnaud, Alice Arabian, Rose Travers et al. · Endocrinology · 2000 · 330 citations · Full text